United States was the largest of Gilead Sciences, Inc.’s 3 reported lines in fiscal 2018, at $32.68B — 73% of $44.53B.
| Geography | FY 2009 | FY 2010 | FY 2011 | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| United States | $42.47B | $38.71B | $36.39B | $32.68B | ||||||
| U.S | — | $38.71B | $36.39B | — | ||||||
| Europe | $15.06B | $12.73B | $10.62B | $8.01B | ||||||
| Other International | — | $9.34B | $5.20B | $3.84B | ||||||
| Other Countries | $7.75B | $9.34B | $5.20B | — | ||||||
| France | — | — | — | — | ||||||
| Spain | — | — | — | — | ||||||
| Switzerland | — | — | — | — | ||||||
| United Kingdom | — | — | — | — | ||||||
| Italy | — | — | — | — | ||||||
| Germany | — | — | — | — | ||||||
| Japan | — | — | — | — | ||||||
| Total | $65.28B | $108.83B | $93.81B | $44.53B |
In fiscal 2018, which ended December 31, 2018, the 3 regions Gilead Sciences, Inc. reported in this breakdown added up to $44.53B. The regions reported changed from fiscal 2017, so the total is not directly comparable with the $93.81B reported that year. United States was the largest region, at $32.68B or 73.4% of the total, followed by Europe ($8.01B, 18.0%) and Other International ($3.84B, 8.6%). Together, the two largest regions made up 91.4% of this total.
Compared with fiscal 2017, every sizeable region reported in both years shrank. United States held up best, down 10.2% to $32.68B, while Other International fell the most, down 26.2% to $3.84B. Because regions were added or dropped between the two years, part of this reflects how Gilead Sciences, Inc. regrouped its reporting.
Other International was first reported as a separate region in fiscal 2016. The table also keeps 9 regions that Gilead Sciences, Inc. no longer reports, so earlier years can still be read on their original basis; use "Show 9 discontinued" beneath the table to see them. This breakdown covers every fiscal year from 2009 to 2018, as reported in Gilead Sciences, Inc.'s annual filings.
United States was the largest of Gilead Sciences, Inc.’s 9 reported lines in fiscal 2008, at $5.71B — 54% of $10.67B.
| Geography | FY 2008 |
|---|---|
| United States | $5.71B |
| France | $791.34M |
| Other Countries | $738.11M |
| Spain | $713.21M |
| Other European Countries | $693.44M |
| United Kingdom | $594.55M |
| Italy | $554.88M |
| Germany | $484.39M |
| Switzerland | $386.63M |
| Total | $10.67B |
In fiscal 2008, which ended December 31, 2008, the 9 regions Gilead Sciences, Inc. reported in this breakdown added up to $10.67B. United States was the largest region, at $5.71B or 53.6% of the total, followed by France ($791.34M, 7.4%) and Other Countries ($738.11M, 6.9%). Together, the two largest regions made up 61.0% of this total.
This breakdown covers every fiscal year from 2008 to 2008, as reported in Gilead Sciences, Inc.'s annual filings.
Gilead Sciences, Inc. (GILD) breaks its revenue down by region. In fiscal 2018, its largest region was United States, with $32.68B or 73.4% of the total, followed by Europe at $8.01B (18.0%).
United States was Gilead Sciences, Inc.'s largest region in fiscal 2018, with $32.68B in revenue, 73.4% of the $44.53B reported across its 3 regions.
Every figure is taken from Gilead Sciences, Inc.'s annual financial filings and shown as reported: each line keeps the name the company gives it, years follow its own fiscal calendar, and lines it has stopped reporting stay in the table for the years they were reported.
The breakdown by region covers fiscal 2009 to 2018. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.